| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3e880662c8ccbc996b7dd814b6b62b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c11eee29d597677596d8764ca8fc9b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d7debf3fc8c97908dfe3876a1336fd4 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-29 |
| filingDate |
2005-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86ea529e8f2eb0056395cd87bb996a75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96740fdd2b33feacdbb53bc0ceab5487 |
| publicationDate |
2006-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006014507-A2 |
| titleOfInvention |
Method for inhibiting lipid peroxidation |
| abstract |
The invention relates generally to the use of N-substituted dopamine derivatives for the treatment of diseases and disorders that involve abnormal lipid peroxidation. This method comprises the administration of a pharmaceutically effective amount of NÂacetyldopamine derivatives or N-alkyldopamine derivatives and a pharmaceutically acceptable carrier for treating an animal or human suffering abnormal lipid peroxidation. The N-acetyldopamine derivative or N-alkyldopamine derivatives may be administered alone or in combination with N-acetylserotonin (NAS) to inhibit lipid peroxidation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013078413-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10226062-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102641358-A |
| priorityDate |
2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |